Entry |
|
Symbol |
Atf4, Atf-4, C/ATF, CREB-2, CREB2, TAXREB67
|
Name |
(RefSeq) activating transcription factor 4
|
KO |
K04374 | cyclic AMP-dependent transcription factor ATF-4 |
|
Organism |
mmu Mus musculus (house mouse)
|
Pathway |
mmu04141 | Protein processing in endoplasmic reticulum |
mmu04261 | Adrenergic signaling in cardiomyocytes |
mmu04925 | Aldosterone synthesis and secretion |
mmu04927 | Cortisol synthesis and secretion |
mmu04928 | Parathyroid hormone synthesis, secretion and action |
mmu04932 | Non-alcoholic fatty liver disease |
mmu04935 | Growth hormone synthesis, secretion and action |
mmu05022 | Pathways of neurodegeneration - multiple diseases |
mmu05163 | Human cytomegalovirus infection |
mmu05166 | Human T-cell leukemia virus 1 infection |
mmu05207 | Chemical carcinogenesis - receptor activation |
|
Brite |
KEGG Orthology (KO) [BR:mmu00001]
09120 Genetic Information Processing
09123 Folding, sorting and degradation
04141 Protein processing in endoplasmic reticulum
11911 (Atf4)
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
11911 (Atf4)
04022 cGMP-PKG signaling pathway
11911 (Atf4)
04151 PI3K-Akt signaling pathway
11911 (Atf4)
09140 Cellular Processes
09141 Transport and catabolism
04137 Mitophagy - animal
11911 (Atf4)
09150 Organismal Systems
09152 Endocrine system
04911 Insulin secretion
11911 (Atf4)
04922 Glucagon signaling pathway
11911 (Atf4)
04915 Estrogen signaling pathway
11911 (Atf4)
04926 Relaxin signaling pathway
11911 (Atf4)
04935 Growth hormone synthesis, secretion and action
11911 (Atf4)
04918 Thyroid hormone synthesis
11911 (Atf4)
04928 Parathyroid hormone synthesis, secretion and action
11911 (Atf4)
04925 Aldosterone synthesis and secretion
11911 (Atf4)
04927 Cortisol synthesis and secretion
11911 (Atf4)
09156 Nervous system
04725 Cholinergic synapse
11911 (Atf4)
04728 Dopaminergic synapse
11911 (Atf4)
04720 Long-term potentiation
11911 (Atf4)
04722 Neurotrophin signaling pathway
11911 (Atf4)
09149 Aging
04211 Longevity regulating pathway
11911 (Atf4)
09160 Human Diseases
09161 Cancer: overview
05207 Chemical carcinogenesis - receptor activation
11911 (Atf4)
05203 Viral carcinogenesis
11911 (Atf4)
09162 Cancer: specific types
05215 Prostate cancer
11911 (Atf4)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
11911 (Atf4)
05161 Hepatitis B
11911 (Atf4)
05163 Human cytomegalovirus infection
11911 (Atf4)
09164 Neurodegenerative disease
05010 Alzheimer disease
11911 (Atf4)
05012 Parkinson disease
11911 (Atf4)
05014 Amyotrophic lateral sclerosis
11911 (Atf4)
05020 Prion disease
11911 (Atf4)
05022 Pathways of neurodegeneration - multiple diseases
11911 (Atf4)
09165 Substance dependence
05030 Cocaine addiction
11911 (Atf4)
05031 Amphetamine addiction
11911 (Atf4)
05034 Alcoholism
11911 (Atf4)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
11911 (Atf4)
09167 Endocrine and metabolic disease
04932 Non-alcoholic fatty liver disease
11911 (Atf4)
04934 Cushing syndrome
11911 (Atf4)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:mmu03000]
11911 (Atf4)
Transcription factors [BR:mmu03000]
Eukaryotic type
Basic leucine zipper (bZIP)
AP-1(-like) components, CRE-BP/ATF
11911 (Atf4)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
Position |
15:80139385..80141746
|
AA seq |
349 aa
MTEMSFLNSEVLAGDLMSPFDQSGLGAEESLGLLDDYLEVAKHLKPHGFSSDKAGSSEWP
AMDDGLASASDTGKEDAFSGTDWMLEKMDLKEFDFDALFRMDDLETMPDELLTTLDDTCD
LFAPLVQETNKEPPQTVNPIGHLPESLIKVDQVAPFTFLQPFPCSPGVLSSTPEHSFSLE
LGSEVDISEGDRKPDSAAYITLIPPCVKEEDTPSDNDSGICMSPESYLGSPQHSPSTSRA
PPDNLPSPGGSRGSPRPKPYDPPGVSLTAKVKTEKLDKKLKKMEQNKTAATRYRQKKRAE
QEALTGECKELEKKNEALKEKADSLAKEIQYLKDLIEEVRKARGKKRVP |
NT seq |
1050 nt +upstreamnt +downstreamnt
atgaccgagatgagcttcctgaacagcgaagtgttggcgggggacttgatgtcccccttc
gaccagtcgggtttgggggctgaagaaagcctaggtctcttagatgactatctggaggtg
gccaagcacttgaaacctcatgggttctccagcgacaaggcgggctcctcggaatggccg
gctatggatgatggcttggccagtgcctcagacaccggcaaggaggatgccttttccggg
acagattggatgttggagaaaatggatctgaaagagtttgacttcgatgctctgtttcga
atggatgacctggaaaccatgccagatgagctcttgaccacgttggatgacacatgtgat
ctttttgcccctctagtccaagagactaataaggagccccctcagacagtgaacccaatt
ggccatctcccagaaagtttaataaaagtcgaccaggttgccccctttacattcttgcag
cctttcccctgttccccaggggttctgtcttccactccagagcattcctttagtttagag
ctaggcagtgaagttgatatctctgaaggagacaggaagcctgactctgctgcttacatt
actctaatccctccatgtgtaaaggaggaagacactccctctgacaatgacagtggcatc
tgtatgagcccagagtcctacctgggctctccccagcatagcccctccacctccagggcc
ccaccagacaatctgccttctccaggtggttcccgtgggtctcctcggcccaaaccttat
gacccacctggagttagtttgacagctaaagtgaagactgagaaattggataagaagctg
aaaaagatggagcaaaacaagacagcagccactaggtaccgccagaagaagcgggctgag
caggaggccctcactggcgagtgtaaggagctagaaaaaaagaatgaggctctgaaagag
aaggcagattctctggccaaggagatccagtatctgaaagacctgatagaagaggtccgt
aaggcaagggggaagaagagagttccgtaa |